28 In people without diabetes but with obesity and pre-existing cardiovascular disease, 2.4 mg semaglutide once weekly was shown to reduce the risk of a composite of death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke by 20% over a median of 3.25 years
The subsequent literature never converged on DSIP being a sleep-inducing agent in any conventional sense, and its own principal investigators repeatedly noted effects that had nothing to do with sleep: stress tolerance, pain, withdrawal syndromes, chronobiological regulation
If you were already active, you can likely continue your existing routine but pay close attention to how you feel, especially on injection days and the 2448 hours that follow
Conagra Brands adds GLP-1 friendly label to some Healthy Choice meals. Food Dive
The oral GLP-1 era has officially begun